Innovative Therapeutics towards Personalized Medicine
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Biomedical Engineering".
Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 1480
Special Issue Editor
Interests: metabolic syndrome; cancer metabolic syndrome
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
With the promise of delivering the right treatment at the right time to the right person, personalized medicine stands at the edge of the innovation revolution in healthcare.
As such, we are currently witnessing a paradigm transformation in healthcare since cutting-edge technologies are rapidly invading and leading the diagnostics and treatments provided to patients worldwide. Technological advances in the fields of engineering, robotics, nano- and micro-technologies, genomics and other ‘omics’, artificial intelligence, and big data are amongst the most relevant scientific breakthroughs improving our knowledge of disease diagnostics and treatment. In that manner, we can provide more precise, predictive, and personalized health care fitted to each individual patient, improving quality of life and reducing healthcare costs.
A major challenge faced by personalized medicine is the development of newer, safer, and custom-made therapeutic forms that do not increase costs and reduce the life cycle for the development of new therapeutic approaches. Patient access to new drugs, devices, and treatments is perhaps the biggest challenge to be solved by personalized medicine in the future.
In this way, research into innovative therapies aims to assist patient access to new forms of therapy through the development of new, economically sustainable, safe, and accessible technologies to improve outcomes for patients and the population.
The goal of this Special Issue is to promote discussions on innovative therapies as alternatives to old problems, such as antibiotic resistance and the treatment of orphan diseases; emerging approaches such as telemedicine and telesurgery; and the use of cutting-edge technologies such as nanofabrication, drug design, and intelligent drug delivery, among others.
Prof. Dr. Rúben Fernandes
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- innovative medicine
- gene therapy
- cell therapy
- immune therapy
- endocrine therapy
- phage therapy
- photodynamic therapy
- hyperbaric oxygen therapy
- biotherapy
- medical devices
- nanomedicines
- computational drug design
